Mask for medical or cosmetic purposes containing micellized extracts

EP4466001A1Pending Publication Date: 2024-11-27SOLMIC BIOTECH GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
EP2023701634
Authority / Receiving Office
EP · EP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-05-13
Filing Date
2023-01-18
Publication Date
2024-11-27

AI Technical Summary

Technical Problem

Existing facial masks for medical or cosmetic use do not effectively deliver active ingredients to the skin for absorption, leading to suboptimal skin care and healing treatment outcomes.

Method used

A ready-to-use facial mask made of flexible biocellulose or similar materials, containing solubilisates of lipophilic active ingredients encapsulated in micelles, which are designed to be readily absorbed by the skin, with perforations for eyes and nose for comfort and adjustable fit, and can cover the face, neck, or décolleté, ensuring effective delivery of anti-aging, therapeutic, and cosmetic benefits.

Benefits of technology

The mask provides stable, long-lasting absorption of active ingredients, improving skin appearance and treating various skin issues like acne, psoriasis, and aging, while being gentle on normal and sensitive skin, with demonstrated stability and effectiveness in dermatological tests.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IMGF000008_0001
    Figure IMGF000008_0001
  • Figure IMGF000009_0001
    Figure IMGF000009_0001
Patent Text Reader

Abstract

The invention relates to a (face) mask for medical or cosmetic purposes, which contains micellized extracts or micellized lipophilic active substances, in particular (face) mask that contains one or more solubilizates of lipophilic active substances on the basis of plant extracts, vegetable extracts, plant parts, phytotherapeutics, resins, vitamins, enzymes, proteins, algae, functional active substances and / or coenzymes, and mixtures and combinations thereof.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Mask for medical or cosmetic purposes with micellar extracts

[0002] The invention relates to a (facial) mask for medical or cosmetic purposes containing micellized extracts or micellized lipophilic active ingredients.

[0003] DE 100 02 350 A1 already discloses a face mask for covering the facial area, which is intended to support the application of ointments or creams to the face by increasing the temperature. So that this face mask can absorb a heating or cooling agent, it consists of a first lower and a second upper film, which are arranged one above the other and welded together along their outer circumference to form a hollow space. To improve wearing comfort, particularly when the face mask is worn for extended periods, it has cutouts for the mouth, nose and eyes. The face mask also has one or two straps for fastening to the head of the mask wearer to prevent it from slipping when the mask wearer lies down or sits down. Finally, to stabilize the shape of the face mask, welded seams are arranged between the two films that form the hollow space for absorbing the heating or cooling agent.

[0004] DE 199 30 838 A1 discloses a face mask for medical or cosmetic purposes, the basic shape of which is adapted to a human face. The mask can be placed on the face outside the mask area for a beauty or skincare treatment or to protect the skin during a treatment. This face mask comprises a central eye, nose, mouth, and cheek area, as well as a forehead and chin area to cover the facial area. Furthermore, it has recesses for the eyes, mouth, and nose. The mask is attached to the wearer's face with lateral retaining means in the form of clips or loops for connecting to the ears.

[0005] EP 0 063 875 A2 relates to a cosmetic facial mask for carrying out cosmetic facial packs containing liquid ingredients.

[0006] EP 2 489 286 A2 discloses a spreadable cosmetic face mask. The present invention is based on the object of providing a ready-to-use mask for cosmetic or medical purposes, in which active ingredients for the care or healing treatment of the skin are prepared in such a way that they are well absorbed by the skin and lead to an improvement in its appearance.

[0007] This object is achieved in a mask according to the invention in detail by

[0008] • that the mask contains solubilisates of lipophilic active ingredients

[0009] • that the mask is made of a flexible material

[0010] • that, if it covers the entire face, it contains perforated cutouts for, for example, the eyes and nose

[0011] To facilitate visual perception and unobstructed breathing during treatment, the mask, if it covers the entire face, has perforated cutouts for the eyes and nose. This increases the user's comfort and allows for individual adjustment. However, the mask can also cover only parts of the face or neck. It is also possible for it to extend to the décolleté or cover other body parts.

[0012] The mask is made of a flexible material. This can be a cellulose-containing material, a cotton-containing material, or a silk-containing material, as well as any combinations and mixtures thereof. Biocellulose is preferred, most preferably a material consisting of 90-98% water and 2-10% cellulose. In a preferred embodiment, masks consisting of 96% water and 4% cellulose are used. The term "biocellulose" refers to a smooth, roughened, or napped, flat fabric material used to make the face mask. The face mask can be made of cellulose or cellulose fleece, in one or more layers. In a preferred embodiment, the biocellulose mask is made from fermented bacteria. It is 100% compostable and, due to its properties, adheres well to the skin. Other preferred features of the biocellulose mask are:

[0013] - Fiber diameter 2-100 nm

[0014] - Length of fibers 1-9 mm 3 D structure

[0015] Alternatively, other flexible materials, such as film materials or materials made of cotton or silk fibers, can also be considered. The thickness of the layer(s) is flexible and depends on the fluid absorption required by the face mask for the specific application.

[0016] The cut of the mask can vary. The mask can cover the entire face, parts of the face, neck, décolleté, or other body parts. The terms "mask" and "face mask" are used interchangeably, and the term "face" should not be interpreted as limiting the face. It acts as a carrier for active substances that can penetrate the skin.

[0017] The masks according to the invention are preferably sterile and individually packaged. In a preferred embodiment, the mask (especially a biocellulose mask) is placed on a moistened nonwoven cloth and covered with a perforated white plastic film, allowing the mask to be folded within the packaging and protecting it from drying out. The packaging is preferably an aluminum film, which can be printed, e.g., using CMYK printing.

[0018] The face mask preferably has perforations for the eyes, nose, and possibly the mouth. Optional openings can be provided in the cheek area to accommodate the wearer's ears. The face is divided into a forehead and chin area, as well as a central eye, nose, mouth, and cheek area. Corresponding areas of the face mask are assigned to these areas. Optional openings for the ears can be located to the sides of the central facial area of ​​the face mask. These openings enclose the ears and securely hold the face mask in place. As a result, the face mask cannot accidentally slip off the face during treatment.

[0019] In a preferred embodiment of the invention, at least one recess is also provided for the nose. This recess is formed by a trapezoidal opening that can have a cutout or incision in the direction of the symmetry axis of the facial surface, extending into the face mask up to the level of the eye area, to allow adaptation to different nose shapes. To activate the nasal opening, the part of the mask enclosed by the perforation is placed on the nose, thus forming a passage for the nose.

[0020] The masks are loaded with solubilized active ingredients. The solubilizes are water-soluble micelles that encapsulate lipophilic substances. Solubilizates are produced with the aim of enclosing lipophilic or insoluble or poorly water-soluble substances in such a way that they become water-soluble. A combination of emulsifier(s), fat-soluble active ingredients, and excipients forms stable, transparent, and water-soluble solubilizes. Preferred emulsifiers are polysorbates, Lutrol, gum arabic, sucrose stearate, DermofeelG 10 LW (70) MB, pasty Dermofeel® G 10 L, PEG-40 hydrogenated castor oil, lecithins, phospholipon, or D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS; also known as Vitamin E TPGS, tocopherol sulfate (INN)). For example, TPGS is an amphiphilic emulsifier that has a hydrophilic and a lipophilic molecular part.A polyethylene glycol moiety forms the polar head, and tocopherol succinate represents the lipophilic tail. This amphiphilic property leads to the self-association (micelle formation) of TPGS in water. Thus, fat-soluble components are enclosed within the micelle (liphophilic part) and dissolved in water through the water-soluble surface of the micelle. Possible excipients for improved solubility of the poorly water-soluble substances include ethanol (96%), polysorbate, and glycerol (anhydrous). For further details on the preparation of the solubilizates, please refer to the contents of the applicant's EP applications EP 3 675 825 (EP 18 738 297) and EP 3 675 824 (EP 18 737 274).

[0021] The active ingredients stably enclosed in micelles are protected from thermal, light influences and / or chemical instability (e.g. oxidation).

[0022] Since the masks consist primarily of water, they can be loaded with micelles. The mask releases its moisture to the skin, along with the active ingredients. Tests have shown that the masks absorb at least 20%, preferably at least 50%, of the solubilizate used in production.

[0023] Possible active ingredients include lipophilic plant extracts, plant extracts, phytotherapeutics, algae, resins, vitamins, enzymes, proteins, functional active substances and / or coenzymes, as well as mixtures and combinations thereof. All of these active ingredients have a positive effect on the skin, which encompasses both cosmetic applications for the care and cleansing of all skin types, particularly for achieving an anti-aging effect, as well as therapeutic applications for skin conditions such as acne, erysipelas, urticaria, herpes, atopic dermatitis, burns, or psoriasis.

[0024] Examples of possible plant extracts or phytotherapeutics are evening primrose (Oenothera biennis), balloon vine (Cardiospermum halicacabum), wild pansy (Viola tricolor), horsetail (Equisetum arvense), German chamomile (Matricaria recutita), witch hazel (Hamamelis virginiana), Oregon grape (Mahonia aquifolium), birch (Betula pendula), ylang-ylang, Siberian ginseng (Eleutherococcus aureus), shea butter (Karite butter), cannabis plant (cannabinoids), turmeric (Curcuma langa), true lavender (Lavandula angustifolia), St. John's wort (Hypericum perforatum), Irish moss (Chondrus crispus), hops (Humulus lupulus), green tea (Camellia sinensis L.), centella (Centella asiatica), mallow (Malva sylvestris), meadowsweet (Filipendula ulmaria), marigold (Calendula officinalis L.) or red clover (Trifolium pratense).

[0025] Examples of possible algae are brown algae, red algae, green algae or blue-green algae.

[0026] Examples of possible vitamins are vitamin E, vitamin A, pro-vitamin A (beta-carotene), vitamin C, vitamin B 3 (niacin), panthenol, provitamin B5 and vitamin B7 (biotin).

[0027] Examples of enzymes, proteins and coenzymes are lipases, cellulases, amylases, proteases, collagen, acetyl hexapeptide-8, pentapeptide-18 or ubiquinone-10 (Q10),

[0028] Examples of possible resins are frankincense, propolis or myrrh.

[0029] Examples of other functional active ingredients are fruit acids (e.g. glycolic acid, lactic acid, malic acid, citric acid, tartaric acid), resveratrol, pterostilbene, astaxanthin or substances that can interact with the functional pathways of hypoxia-induced factor (HIF), mTor, p53, GDNF, GLUT1.

[0030] Particularly preferred solubilisates are: micellized Q10 or astaxanthin -> Application: anti-wrinkle, energy booster, antioxidant micellized frankincense -> Application: antibacterial, anti-inflammatory micellized propolis -> Application: antibacterial, anti-inflammatory micellized Siberian ginseng, resveratrol, pterostilbene or HIF inhibitors -> Application: anti-aging, anti-wrinkle, antibacterial, anti-inflammatory

[0031] One or more other (water-soluble) substances that have a positive effect on the skin can be added to the solubilisate or applied directly to the mask, e.g. hyaluronic acid, aloe vera, centella extract, green tea extract, lactic acid, urea or amino acids.

[0032] Furthermore, cosmetic or pharmaceutical excipients such as preservatives, thickeners or binding agents may also be present.

[0033] As shown in the examples, the solubilisates in the masks and also in the surrounding essence remain stable over a longer period of time, i.e. they do not show any degradation.

[0034] Furthermore, dermatological tests were conducted on the above-mentioned solubilized active ingredient-laden masks. All masks are suitable for normal and sensitive skin. This means that the micelles are particularly gentle on the skin.

[0035] The invention is explained in more detail below with reference to Figures 1 and 2.

[0036] Figure 1 shows a biocellulose face mask according to the invention, which is placed on a nonwoven fabric.

[0037] (1) Nonwoven layer

[0038] (2) Biocellulose mask

[0039] Figure 2 shows a face mask according to the invention, showing the existing perforations for eyes, nose and mouth.

[0040] (3) Perforated plastic film

[0041] The invention is illustrated by the following examples. Example 1: Loading the masks

[0042] The cut mask is placed in an airtight package and loaded with the essence containing solubilized ubiquinone at the filling machine. The machine dispenses a specific amount of 15-45 g of essence into the finished package. By repeatedly pressing the side of the package, the essence is evenly distributed to ensure the mask is completely coated with the essence. The package is then sealed. After storage for 3-7 days, the mask is saturated with the essence.

[0043] Preparation of the essence:

[0044] Further features of the biocellulose mask

[0045] - Fiber diameter 2-100 nm

[0046] - Fiber length 1-9 mm

[0047] - 3D structure

[0048] Example 2: Measurement of solubilisates from masks regarding stability

[0049] The solubilisates of various active ingredients were extracted from corresponding masks and measured for their stability.

[0050] To investigate the stability of the solubilisates, the ingredients in the mask and essence were identified and measured over a period of three months at room temperature and 40°C. Q10, Siberian ginseng, propolis, and frankincense solubilisates were analyzed. During the development of the analytical method, it was determined that at least 50% of the raw material concentration used can be recovered in the masks. This can be explained by diffusion. Before the biocellulose mask is placed in the essence, i.e., the prefabricated mask, which contains up to 98% of its total weight in water, the molar concentration is equalized. The mask absorbs at least 50% of the active ingredient. The determined initial molar concentration is the starting value of the zero measurement and represents 100% of the initial value.

[0051] Q10 Bioceiiulose Mask Reconditioning

[0052] The mask, immersed in 3% essence solution, was cut into approximately 1 g pieces and placed in a tube containing approximately 4 g of tetrahydrofuran (THF). The sample was immersed for at least 4 hours. During the extraction time, the sample material was vortexed in the tube. The total weight of the mask sample and that of the solvent were added and recorded. 100 μl of the solution containing the sample was removed and mixed with 900 μl of methanol / 1-propanol (50 / 50 v / v). The sample was then analyzed using HPLC-UV.

[0053] The concentration in the extracted solution was determined using a 6-point calibration curve ranging from 1 to 100 μg / ml. Quality control samples, which must meet a predefined value (3 μg / ml, 50 μg / ml, 80 μg / ml) during a run, served as controls. After measuring the extraction, approximately 50% of the raw material used was recovered. The essence was also measured. The determined and validated value was used as the initial value.

[0054] Siberian Ginseng Biocellulose Mask Reprocessing

[0055] The mask, immersed in a 3% essence solution, was cut into approximately 1 g pieces and placed in a tube containing approximately 4 g of water (H2O). The sample material was vortexed in the tube during the extraction period. The total weight of the mask sample and that of the solvent were added and recorded.

[0056] 200 μl of the solution containing the sample was taken and mixed with 800 μl of methanol / water (50 / 50 v / v). The sample was then analyzed using HPLC-UV. Ferulic acid was used as the reference standard, as described in Ph.Eur 9.0 / 1419. This allowed the eleutheroside B content to be calculated. For comparison, the Siberian ginseng solubilisate used was diluted to 3%, analogous to the mask essence, to determine the eleutheroside B content. Based on the value determined in the diluted solubilisate, the deviation in the essence and the mask could be determined. 57% of the active ingredient used was recovered. This value was used as the initial value.

[0057] Frankincense Biocellulose Mask Reprocessing

[0058] The mask, immersed in 3% essence solution, was cut into approximately 1 g pieces and placed in a tube containing approximately 4 g of tetrahydrofuran (THF). The sample material was vortexed in the tube during the extraction period. The total weight of the mask sample and that of the solvent were added and recorded.

[0059] 1000 μl of the solution containing the sample was taken and first centrifuged and then measured using HPLC-UV.

[0060] Using a 4-point calibration curve between 10 and 200 μg / ml, boswellic acid (AKBA) was used as a reference standard to determine the concentration in the extracted solution. The essence and the solubilizate used were also measured. After measuring the extraction, approximately 50% of the raw material used was recovered. The determined and validated value was used as the initial value.

[0061] Propolis biocellulose mask processing

[0062] The mask, immersed in a 3% essence solution, was cut into approximately 1 g pieces and placed in a tube containing approximately 4 g of water / acetonitrile (90 / 10 v / v). The sample material was vortexed in the tube during the extraction period. The total weight of the mask sample and that of the solvent were added and recorded.

[0063] 1000 μl of the solution containing the sample was taken and first centrifuged and then measured using HPLC-UV.

[0064] Using a 4-point calibration curve between 2 and 20 μg / ml of chrysin as a reference standard, the concentration in the extracted solution was determined. The essence and the solubilizate used were also measured. After measuring the extraction, approximately 66% of the raw material used was recovered. The determined and validated value was used as the initial value.

[0065] The measurement data of the solubilisates in the masks are as follows: Biocellulose Masks Propolis Solubilisate Chrysin Measurement time

[0066] Sample number: Material Condition t=O t= 30 days t= 90 days 230921-A01 Mask Room temperature 100 98.54 102.55 (%) 230921-A01 Mask 40°C 100' 91.85 89.84 (%)

[0067] 2230921-A01 Pure solution room temperature 100 103.25 104.90 (%) 230921-A01 Pure solution 40°C 100 86.96 81.80 (%)

[0068] Biocellulose masks

[0069] Ubiquinone Q10

[0070] Measurement time

[0071] Sample number: Material Conditions t= 30 days t= 90 days

[0072] 230921-A05 Mask .Room temperature 75.06. 63.57' (%)

[0073] 230921-A05 Mask 40°C 62.30' 45.08 (%)

[0074] 230921- A05 Pur Lsg Solution Room temperature 100.00 71.73 63.34 (%)

[0075] 230921-A05 Pure solution 40°C 100.00 67.65; 55.23 (%)

[0076] Biocellulose masks

[0077] Siberian Ginseng Solubilisate

[0078] Eleutheroside B determination measurement time

[0079] Sample number: Material Conditions t=0 t= 30 days t= 90 days

[0080] 23O921-AO4 Mask Room Temperature 100.00! 96.32 91.92! (%)

[0081] 230921-A04 Mask 40°C 100.00! 92.96 85.50! (%)

[0082] 230921-A04 Pur Lsg Solution Room temperature 100.00' 94.10 94.13>(%)

[0083] 230921-A04 Pure solution 40°C 100.00 93.65 93.07 (%)

[0084] Biocellulose masks

[0085] Frankincense solubilizate

[0086] Boswellic acid measurement time

[0087] Sample number: Material Condition t=0 t= 30 days t= 90 days Unit

[0088] 230921-A03 Mask Room Temp 100 108.47 100.88 (%)

[0089] 230921-A03 Mask 40°C 100 99.82 98.21 (%)

[0090] The measurement data show that the concentration of raw materials used must be taken into account, as a material equilibrium occurs due to diffusion. The solubilisates in the masks remain stable, as does the liquid surrounding the masks (essence) containing the solubilisates. Assuming storage at 40°C, the stability of the solubilisates in the masks is guaranteed for at least 12 months.

Claims

Patent claims 1) (Face) mask comprising one or more solubilisates of lipophilic active ingredients from plant extracts, plant parts, phytotherapeutics, resins, vitamins, enzymes, proteins, algae, functional active substances and / or coenzymes, as well as mixtures and combinations thereof. 2) Mask according to claim 1, wherein the plant extracts, plant extracts or phytotherapeutic agents are derived from evening primrose (Oenothera biennis), balloon vine (Cardiospermum halicacabum), wild pansy (Viola tricolor), horsetail (Equisetum arvense), German chamomile (Matricaria recutita), witch hazel (Hamamelis virginiana), Oregon grape (Mahonia aquifolium), birch (Betula pendula), ylang-ylang, Siberian ginseng (Eleutherococcus), shea butter (Karitebutter), cannabis plant (cannabinoids), turmeric (Curcuma langa), English lavender (Lavandula angustifolia), St. John's wort (Hypericum perforatum), Irish moss (Chondrus crispus), hops (Humulus lupulus), green tea (Camellia sinensis L.), and centella (Centella). asiatica), Mallow (Malva sylvestris), Meadowsweet (Filipendula ulmaria), Marigold (Calendula officinalis L.), Red clover (Trifolium pratense) originate. 3) Mask according to claim 1, wherein the vitamins are vitamin E, vitamin A, pro-vitamin A (beta-carotene), vitamin C, vitamin B3 (niacin) and / or vitamin B7 (biotin). 4) Mask according to claim 1, wherein the enzymes, proteins or coenzymes are lipases, cellulases, amylases, proteases, collagen, acetyl hexapeptide-8, pentapeptide-18 and / or ubiquinone-10 (Q10). 5) Mask according to claim 1, wherein the resins are frankincense, propolis or myrrh. 6) Mask according to claim 1, wherein the functional active substances are astaxanthin, resveratrol, pterostilbene, fruit acids or substances that can interact with the functional pathways of hypoxia-induced factor (HIF), mTor, p53, GDNF, GLUT1. 7) Mask according to one of claims 1-6, wherein the solubilisates are a combination of emulsifier(s), fat-soluble active ingredients and excipients. 8) Mask according to claim 7, wherein the emulsifier is selected from polysorbates, Lutrol and / or D-alpha-tocopheryl polyethylene glycol 1000 succinate. 9) Mask according to claim 7 or 8, wherein the excipients are ethanol, polysorbate and / or glycerin. 10) Mask according to any one of claims 1-9, wherein it is made from biocellulose. 11) Use of the mask according to any one of claims 1-10 for cosmetic purposes. Purposes for the care and cleansing of all skin types. 12) Use according to claim 11, wherein an anti-aging effect of the skin is achieved. 13) Use of the mask according to one of claims 1-10 for therapeutic application in skin diseases. 14) Use of the mask according to claim 14, wherein the skin disease is acne, herpes, neurodermatitis, urticaria, erysipelas, burns or psoriasis.